Canopy Growth director granted 162,485 CGC shares
Lazzarato David Angelo reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lazzarato David Angelo reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director David Angelo Lazzarato received an equity award of 162,485 Common Shares on June 17, 2026. The award was granted at no cash cost to him as a compensation-related grant, not an open-market purchase.
The grant was made in the form of restricted stock units that vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026, and March 29, 2027. Following this grant, he directly holds 234,533 Common Shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 162,485 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares reported herein were granted on June 17, 2026, in the form of restricted stock units ("RSUs"). These RSUs vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026 and March 29, 2027.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Canopy Growth Corp director David Angelo Lazzarato report on this Form 4 for CGC?
Was the CGC insider transaction by David Angelo Lazzarato a stock purchase or a grant?
How do the restricted stock units granted to the CGC director vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.